Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology
Authors:
- 4 July 2006
- journal article
- review article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 114 (s185) , 8-14
Abstract
The unique structural and biophysical features of apolipoprotein (apo) E4 – domain interaction and molten globule formation – have been correlated with the detrimental effects of apoE4 in neuropathology. Two examples of how the structure of apoE4 determines the pathological outcome in neurons include apoE4 potentiation of amyloid β‐induced lysosomal leakage and apoptosis and the proteolytic cleavage of apoE synthesized by neurons. Thus, a new therapeutic target is to identify small molecules to modulate the inherent neuropathological structure of apoE4, i.e. to prevent domain interaction and to convert apoE4 to an apoE3‐like molecule. A second therapeutic target is to inhibit the apoE‐cleaving enzyme. This would prevent the generation of the reactive carboxyl‐terminal fragments of apoE that enter the cytosol, disrupt the cytoskeleton, and cause neurodegeneration. ApoE4 is more susceptible than apoE3 to proteolytic cleavage and is thus more likely to cause detrimental effects in the central nervous system. It is predictable that apoE4 acts through various pathways to cause cognitive decline and neurodegeneration.Keywords
This publication has 74 references indexed in Scilit:
- Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosisNeurology, 2001
- APOE genotype as a risk factor for ischemic cerebrovascular diseaseNeurology, 1999
- Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injuryNeurology, 1999
- Association of apolipoprotein E polymorphism with outcome after head injuryThe Lancet, 1997
- APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASEAnnual Review of Medicine, 1996
- Amyloid β‐Protein, APOE Genotype and Head InjuryAnnals of the New York Academy of Sciences, 1996
- ApoE genotype and survival from intracerebral haemorrhageThe Lancet, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's diseaseNeurology, 1993
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences, 1993